Is NRC Health (NRC) Overvalued?
We dive into why NRC Health (NRC) could be considered overvalued on 2026-08-14, based on AAII’s Value Score and Grade.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Rosalio Madrigal
Jenna Brashear
Omar Beirat
Cynthia McLaughlin
| Share Statistics | NRC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $482.6 | $1,982.5 | 36% |
|
| Shares Out (Mil) | 22.0 | 77.7 | 32% |
|
| Institutional Ownership | 52.1% | 86.1% | 36% |
|
| Float (Mil) | 11.8 | 52.1 | 21% |
|
| Beta | 0.37 | 0.75 | 21% |
|
| Avg Daily Volume (000s) | 129 | 637 | 38% |
|
| Price Change (52-week) |
34.9% | 79.7% | 72% |
|
| Growth | NRC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 0.6% | 10.9% | 19% |
|
| Net Income (5yr) | (20.8%) | (1.6%) | 19% |
|
| EPS (5yr) | (19.2%) | 0.3% | 14 |
|
| Dividends (5yr) | 19.9% | 0.0% | 71% |
|
| Cash Flow (5yr) | (14.9%) | (17.9%) | 53% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | $0.210 | $0.980 | $1.050 | |
| Month Ago EPS | $0.210 | $0.810 | $1.070 | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | (240.0%) | 96.0% | na | |
| Financials | NRC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $140 | $1,504 | 29% |
|
| Net Income (TTM) (Mil) | $6 | $28 | 43% |
|
| EPS (TTM) | $0.250 | $0.200 | 48% |
|
| Operating Cash Flow (TTM) (Mil) | $30 | $162 | 43% |
|
| Net Cash Flow (TTM) (Mil) | ($2) | $9 | 38% |
|
| Long-Term Debt (Q1) (Mil) | $86 | $338 | 43% |
|
| Enterprise Value (Q1) (Mil) | $519 | $2,416 | 35% |
|
| Valuation | NRC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 72.73 | 2.79 | 99% |
|
| P/E | 90.9 | 25.8 | 92% |
|
| Dividend Yield | 2.9% | 0.0% | 84% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | NRC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 61.7% | 27.8% | 74% |
|
| Net Margin | 4.2% | 1.2% | 45% |
|
| ROA | 4.2% | 2.2% | 68% |
|
| ROE | 42.0% | 7.2% | 91% |
|
| Liabilities to Assets | 95.2% | 58.6% | 92% |
|
| F-Score | 6 | 5 | 67% |
|
NRC Health did not pass any screens on 8/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors